Cargando…
Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy
We report a simple strategy to prepare Tween 60@2β-CD self-assembly vesicles in aqueous solution as a new drug delivery carrier for cancer chemotherapy. The spherical shape of vesicles was confirmed by transmission electron microscopy (TEM) and mean particle sizes were about 33.7 nm, as measured by...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025689/ https://www.ncbi.nlm.nih.gov/pubmed/29463124 http://dx.doi.org/10.1080/10717544.2018.1440448 |
_version_ | 1783498555846033408 |
---|---|
author | Yuan, Yue Zhang, Qin Yan, Yun Gong, Miaomiao Zhao, Qi Bao, Zhihong Liu, Kaerdun Wang, Siling |
author_facet | Yuan, Yue Zhang, Qin Yan, Yun Gong, Miaomiao Zhao, Qi Bao, Zhihong Liu, Kaerdun Wang, Siling |
author_sort | Yuan, Yue |
collection | PubMed |
description | We report a simple strategy to prepare Tween 60@2β-CD self-assembly vesicles in aqueous solution as a new drug delivery carrier for cancer chemotherapy. The spherical shape of vesicles was confirmed by transmission electron microscopy (TEM) and mean particle sizes were about 33.7 nm, as measured by dynamic light scattering, micro-IR results indicated that the self-assembly vesicles was driven by hydrogen bonding. Hydrophilic doxorubicin (DOX) was successfully loaded into the self-assembly vesicles with drug loading content of 7.85% and loading efficiency of 42%. In addition, an in vitro cytotoxicity study and cellular uptake assays demonstrated that the DOX-loaded Tween 60@2β-CD vesicles markedly enhanced the cellular uptake and cytotoxicity of DOX toward the Hela cells. Furthermore, when used to evaluate the in vivo therapeutic efficacy in mice bearing the breast cell line (4T1), DOX-loaded vesicles exhibited superior inhibition of tumor growth compared with the DOX solutions. |
format | Online Article Text |
id | pubmed-7025689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-70256892020-02-27 Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy Yuan, Yue Zhang, Qin Yan, Yun Gong, Miaomiao Zhao, Qi Bao, Zhihong Liu, Kaerdun Wang, Siling Drug Deliv Research Article We report a simple strategy to prepare Tween 60@2β-CD self-assembly vesicles in aqueous solution as a new drug delivery carrier for cancer chemotherapy. The spherical shape of vesicles was confirmed by transmission electron microscopy (TEM) and mean particle sizes were about 33.7 nm, as measured by dynamic light scattering, micro-IR results indicated that the self-assembly vesicles was driven by hydrogen bonding. Hydrophilic doxorubicin (DOX) was successfully loaded into the self-assembly vesicles with drug loading content of 7.85% and loading efficiency of 42%. In addition, an in vitro cytotoxicity study and cellular uptake assays demonstrated that the DOX-loaded Tween 60@2β-CD vesicles markedly enhanced the cellular uptake and cytotoxicity of DOX toward the Hela cells. Furthermore, when used to evaluate the in vivo therapeutic efficacy in mice bearing the breast cell line (4T1), DOX-loaded vesicles exhibited superior inhibition of tumor growth compared with the DOX solutions. Taylor & Francis 2018-02-20 /pmc/articles/PMC7025689/ /pubmed/29463124 http://dx.doi.org/10.1080/10717544.2018.1440448 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Yuan, Yue Zhang, Qin Yan, Yun Gong, Miaomiao Zhao, Qi Bao, Zhihong Liu, Kaerdun Wang, Siling Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title | Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title_full | Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title_fullStr | Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title_full_unstemmed | Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title_short | Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
title_sort | designed construction of tween 60@2β-cd self-assembly vesicles as drug delivery carrier for cancer chemotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025689/ https://www.ncbi.nlm.nih.gov/pubmed/29463124 http://dx.doi.org/10.1080/10717544.2018.1440448 |
work_keys_str_mv | AT yuanyue designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT zhangqin designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT yanyun designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT gongmiaomiao designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT zhaoqi designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT baozhihong designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT liukaerdun designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy AT wangsiling designedconstructionoftween602bcdselfassemblyvesiclesasdrugdeliverycarrierforcancerchemotherapy |